Monoclonal antibodies as drugs
โ Scribed by S. Michael Owens
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 35 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Hybridomas which secrete monoclonal antibodies (MAbs) reacting with doxorubicin (DXR), a widely used anthracycline cytotoxic antibiotic, have been obtained by fusing NSO/P3 mouse myeloma cells with spleen cells from BALBlc mice immunized with DXR-BSA conjugate. The best producer among the several cl
Heterogeneity of monoclonal antibodies is common due to the various modifications introduced over the lifespan of the molecules from the point of synthesis to the point of complete clearance from the subjects. The vast number of modifications presents great challenge to the thorough characterization
Using a synthetic peptide mimicking the NH,-terminus of p-actin we have raised a monoclonal antibody specific for this cytoplasmic actin isoform. Specificity of the antibody was demonstrated by its labelling of the actin polypeptide only in tissues containing the p isoform, by its exclusive recognit
n 3 Nitrate 2 hre 5.21 \* 0.065 9.87 \* 0.82 37.4 \* 8.83 9.36 0.47 1.47 \* 0.06 78 24 hre 7.7 2 1.5 6.0 \_+ 0.5 27.6 \_+ 1.0 12.1 \_+ 0.7 0.4 \_+ 0.15 58 48 hre 1.8 \* 0.32 3.34 \* 0.73 15.2 \* 1.69 13.3 \* 1.05 0.44 \* 0.21 61 -11 3-DTPAC 3 hr 1.09 \* 0.04 1.24 \* 0.11 5.46 \* 0.26 1.00 \* 0.06 -7